def get_data():
  return {'SARS-Cov-2': {'mRNA': 1, 'Pfizer': 3, 'nucleic acid test': 1, 'Coulomb blockade': 1, 'BioNTech': 1, 'Lipoxins': 1, 'transmembrane protease serine': 1, 'amino acid': 1, 'MetaDisc': 1, 'antibiotic': 3, 'antifungal': 3, 'antiperistaltic': 1, 'probiotics': 1, 'antibacterials': 1, 'fibrinolysis': 2, 'procoagulant': 1, 'antifibrinolytic': 1, 'tPA': 2, 'melatonin': 3, 'Melatonin': 1, 'biosensing': 1, 'autoepitopes': 1, 'thromboprophylaxis': 2, 'Netherlands': 1, 'Germany': 1, '-10.60': 1, 'albumin': 1, 'steroids': 2, 'aOR': 1, 'sotrovimab': 1, 'regdanvimab': 1, 'Australia (sotrovimab, REGEN-COV2)': 1, 'sintilimab': 1, 'tezepelumab': 1, 'clonazepam': 1, 'methylprednisolone': 1, 'ocrelizumab': 1, '12/08/2021': 1, 'FIBTEM': 1, 'Thromboelastometric': 1, 'dimethyl fumarate (DMF)': 1, 'Chan Zuckerberg Biohub (JLD)': 1, 'RObust': 1, 'Shufeng': 1, 'TCMSP': 1, 'TCMID': 1, 'Kyoto': 2, 'Quercetin': 1, 'Baicalein': 1, 'Glabrene': 1, 'Glucobrassicin': 1, 'Isoglycyrol': 1, 'Luteolin': 1, 'thyrotoxic': 1, 'casirivimab': 2, 'imdevimab': 3, 'Casirivimab': 1, 'imdevimab antibody combination vs': 1, 'betamethasone sodium phosphate/fradiomycin sulfate': 1, '6MP': 1, 'azathioprine': 1, 'methotrexate': 1, 'sulfasalazine': 1, 'immunosuppressive medications': 1, 'hormone melatonin': 1, 'luteolin': 1, 'quercetin': 1, 'amino acid transport': 1, 'amino acids': 1, 'heparin': 4, 'antibiotics': 1, 'aspirin': 1, 'hydrocortisone': 1, 'Coronaviridae': 2, 'hydroxychloroquine': 1, 'azithromycin': 1, 'Corticosteroids': 1, 'cyclophosphamide': 2, 'October': 1, 'packed red blood cell (pRBC)': 1, 'angiotensin receptor blocker (ARB)': 1, 'diuretics': 1}, 'coronavirus disease 2019': {'antifungal': 3, 'nucleic acid test': 1, 'Coulomb blockade': 1, 'QFPDD': 1, 'transmembrane protease serine': 1, 'ACE inhibitors (ACEIs)': 1, 'ACEI': 2, 'September': 7, 'oxygen': 2, '12/08/2021': 1, 'Mefenamic acid': 1, 'nonsteroidal': 1, 'antipyretic': 1, 'analgesic': 1, 'mefenamic acid combined with standard medical care vs. standard medical care plus a placebo in ambulatory patients with coronavirus disease 2019 (COVID19; nasal/oropharyngeal swabs reverse transcriptionPCR test results positive for severe acute respiratory syndrome coronavirus 2)': 1, 'doubleblind': 1, 'mefenamic acid group (P=0.020, KaplanMeier analyses using logrank tests)': 1, 'mefenamic acid plus standard medical care had a': 1, 'mefenamic acid group': 1, 'mefenamic acid markedly reduced the symptomatology and time to reach PASS in ambulatory patients with COVID19': 1, 'mefenamic acid': 1, 'amino acid transport': 1, 'Instagram': 4, 'Facebook': 1, 'voriconazole': 1, 'Khulna': 1, '245/1,673': 1, 'steroids': 1, 'cyclophosphamide': 2, 'Pfizer': 2, 'AstraZeneca': 2, 'CYC': 1, 'rituximab': 1, 'polyethylene glycol (PEG)-NaCl, incubation period': 1, 'PEG-NaCl': 1, 'Embase': 1, 'Scopus': 1, 'February': 1, 'Lohani': 1, 'August': 2, 'January': 1, '2021;25(12):1382': 1, 'methylprednisolone': 6, 'dexamethasone': 2, 'HFNC': 2, 'heparin': 1, 'telementoring': 2, 'NPIs': 1, 'intravitreal': 1, 'ranibizumab': 1, 'IMV': 1, 'Corticosteroids': 1, 'corticosteroids': 4, 'corticosteroid': 2, 'November': 2, 'antagonist monoclonal antibody': 1, 'tocilizumab': 4, 'chloroquine': 2, 'diuretics': 1, 'Hubei': 1, 'ivermectin': 1, 'azithromycin': 1, 'vitamin C': 1, 'zinc': 1}, 'coronavirus disease': {'antifungal': 3, 'nucleic acid test': 1, 'Coulomb blockade': 1, 'QFPDD': 1, 'transmembrane protease serine': 1, 'ACE inhibitors (ACEIs)': 1, 'ACEI': 2, 'September': 5, 'Lundman': 1, 'oxygen': 1, '12/08/2021': 1, 'Mefenamic acid': 1, 'nonsteroidal': 1, 'antipyretic': 1, 'analgesic': 1, 'mefenamic acid combined with standard medical care vs. standard medical care plus a placebo in ambulatory patients with coronavirus disease 2019 (COVID19; nasal/oropharyngeal swabs reverse transcriptionPCR test results positive for severe acute respiratory syndrome coronavirus 2)': 1, 'doubleblind': 1, 'mefenamic acid group (P=0.020, KaplanMeier analyses using logrank tests)': 1, 'mefenamic acid plus standard medical care had a': 1, 'mefenamic acid group': 1, 'mefenamic acid markedly reduced the symptomatology and time to reach PASS in ambulatory patients with COVID19': 1, 'mefenamic acid': 1, 'February': 2, 'January': 2, 'amino acid transport': 1, 'Instagram': 4, 'Facebook': 1, 'antibiotics': 1, 'aspirin': 1, 'hydrocortisone': 2, 'voriconazole': 1, 'Khulna': 1, '245/1,673': 1, 'steroids': 1, 'cyclophosphamide': 2, 'Pfizer': 1, 'AstraZeneca': 2, 'AYUSH': 1, 'Unani': 1, 'CYC': 1, 'rituximab': 1, 'polyethylene glycol (PEG)-NaCl, incubation period': 1, 'PEG-NaCl': 1, 'Embase': 1, 'Scopus': 1, 'Lohani': 1, 'August': 2, '2021;25(12):1382': 1, 'methylprednisolone': 2, 'dexamethasone': 3, 'HFNC': 2, 'steroid': 2, 'estradiol': 3, 'progesterone': 1, 'testosterone': 1, 'prednisone': 1, 'calcitriol': 4, 'heparin': 1, 'telementoring': 2, 'NPIs': 1}, 'venous thromboembolism': {'anticoagulation': 27, 'anticoagulants': 8, 'aspirin': 19, 'Aspirin': 4, 'spondylarthritis': 1, 'rituximab': 1, 'nonsteroidal': 1, 'August': 1, 'progesterone': 1, 'desogestrel': 1, 'norethindrone': 1, 'megestrol': 1, 'norprogesterones': 1, 'levonorgestrel': 2, 'tamoxifen': 10, 'chemotherapy': 5, 'Streptokinase': 1, 'urokinase': 1, 'warfarin': 11, 'October': 1, 'Unfractionated': 1, 'heparin': 18, 'fondaparinux': 2, 'ADP receptor inhibitor': 1, 'thrombin inhibitor': 1, 'p<0.001': 1, 'chemoprophylactic': 1, 'Adenomyosis': 1, 'Embase': 1, 'MEDLINE': 2, 'Warfarin': 2, 'rivaroxaban': 1, 'apixaban': 11, 'DOACs': 2, 'Subcutanous': 1, 'VTE': 7, 'UFH': 1, 'platelet': 1, 'anticoagulant': 4, 'postmenopausal hormone therapy (HT)': 1, 'HT': 1, 'progestin': 1, 'January': 7, 'Youden': 2, 'SSI': 2, 'antibiotic': 1, 'cefazolin': 1, 'metronidazole': 1, 'chlorhexidine': 1, 'morphine': 1, 'dabigatran': 5, 'thrombolytics': 1, 'serotonin reuptake inhibitors': 1, 'acetaminophen': 1, 'metformin': 4, '13,835 initiators of sulfonylurea': 1, 'GCS': 1, 'PTP': 1, 'corticosteroid': 2, 'EXTEM': 1, 'FIBTEM': 1, 'MCF': 1, 'statin': 2, 'atorvastatin': 7, 'Atorvastatin': 1, 'NOAC': 2, 'megakaryopoiesis': 1, 'testosterone': 3, 'Tranexamic acid': 1, 'TXA': 2, 'statins': 1, 'nitric oxide donors': 1, 'neuraxial': 1, 'anesthesia': 1, 'analgesia': 1, 'opioids': 1, 'polymerization inhibitor': 1, 'voxelotor': 1, 'thrombophilias': 1, 'aOR': 1, 'thalidomide': 1, 'lenalidomide': 1, 'dexamethasone': 1, 'enoxaparin': 6, '41,680': 1, 'underexamined': 1, 'Anticoagulation': 2, 'vitamin k antagonists (VKAs)': 1, 'VKAs': 6, 'anticoagulant drugs [either vitamin k antagonists (VKA)': 1, 'Corticosteroids': 1, 'methylprednisolone': 13, 'aromatase inhibitors': 9, 'vitamin K antagonist': 1, 'DOAC': 1, 'Wilcoxon': 1, 'procoagulant phospholipids': 1, 'Japan': 1, 'HFS': 1, 'steroids': 1, 'oestrogens': 1, 'edoxaban': 1, 'vitamin K antagonists (VKAs; SUCRA 5.1)': 1, 'Heparin': 1}, 'Coronavirus disease 2019': {'antifungal': 3, 'nucleic acid test': 1, 'Coulomb blockade': 1, 'QFPDD': 1, 'transmembrane protease serine': 1, 'ACE inhibitors (ACEIs)': 1, 'ACEI': 2, 'September': 7, 'oxygen': 2, '12/08/2021': 1, 'Mefenamic acid': 1, 'nonsteroidal': 1, 'antipyretic': 1, 'analgesic': 1, 'mefenamic acid combined with standard medical care vs. standard medical care plus a placebo in ambulatory patients with coronavirus disease 2019 (COVID19; nasal/oropharyngeal swabs reverse transcriptionPCR test results positive for severe acute respiratory syndrome coronavirus 2)': 1, 'doubleblind': 1, 'mefenamic acid group (P=0.020, KaplanMeier analyses using logrank tests)': 1, 'mefenamic acid plus standard medical care had a': 1, 'mefenamic acid group': 1, 'mefenamic acid markedly reduced the symptomatology and time to reach PASS in ambulatory patients with COVID19': 1, 'mefenamic acid': 1, 'amino acid transport': 1, 'Instagram': 4, 'Facebook': 1, 'voriconazole': 1, 'Khulna': 1, '245/1,673': 1, 'steroids': 1, 'cyclophosphamide': 2, 'Pfizer': 2, 'AstraZeneca': 2, 'CYC': 1, 'rituximab': 1, 'polyethylene glycol (PEG)-NaCl, incubation period': 1, 'PEG-NaCl': 1, 'Embase': 1, 'Scopus': 1, 'February': 1, 'Lohani': 1, 'August': 2, 'January': 1, '2021;25(12):1382': 1, 'methylprednisolone': 6, 'dexamethasone': 2, 'HFNC': 2, 'heparin': 1, 'telementoring': 2, 'NPIs': 1, 'intravitreal': 1, 'ranibizumab': 1, 'IMV': 1, 'Corticosteroids': 1, 'corticosteroids': 4, 'corticosteroid': 2, 'November': 2, 'antagonist monoclonal antibody': 1, 'tocilizumab': 4, 'chloroquine': 2, 'diuretics': 1, 'Hubei': 1, 'ivermectin': 1, 'azithromycin': 1, 'vitamin C': 1, 'zinc': 1}, 'infection': {'mRNA': 1, 'Pfizer': 1, 'antifungal': 5, 'chemotherapy': 1, 'PsychInfo': 1, 'GIIs': 1, 'heparin': 1, 'vitamin K antagonists)': 1, 'rivaroxaban': 1, 'antibiotics': 8, 'anticoagulation': 1, 'rTKAs': 1, 'QFPDD': 1, 'Ferrous iron': 1, 'iron sulfide nanomaterial': 1, 'interleukin (IL)-1beta, IL-6': 1, 'IL-8': 3, 'interferon regulatory factor': 1, 'Lipoxins': 1, 'antibiotic': 9, 'clarithromycin': 1, 'metronidazole': 1, 'levofloxacin': 1, 'amoxicillin': 1, 'Gingipains': 1, 'A8': 1, 'COX-2': 1, 'benzyllawsone': 1, 'LT-9': 2, 'MetaDisc': 1, 'chlorhexidine gluconate (CHG) bathing to decrease healthcare associated infections (HAI)': 1, 'probiotics': 3, 'antifungals': 1, 'Pseudocitrobacter': 1, 'cephalosporins': 1, 'carbapenems': 1, 'chloramphenicol': 1, 'trimethoprim-sulfamethoxazole': 1, 'amikacin': 1, 'Opisthorchiidae': 1, 'Heterophyidae': 1, 'Schistosomatidae': 1, 'antiperistaltic': 1, 'antibacterials': 1, 'sacubitril': 1, 'valsartan': 1, 'fibrinolysis': 2, 'procoagulant': 1, 'antifibrinolytic': 1, 'tPA': 2, 'biosensing': 1, 'autoepitopes': 1, '78,916 unigenes': 1, 'January': 3, 'October': 2, 'TPN': 1, 'thromboprophylaxis': 2, 'DW': 1, 'microg': 1, 'PWNs': 1, 'Netherlands': 2, 'Germany': 1, 'Belgium': 1, 'Greece': 1, 'Poland': 1, 'Sweden': 1, 'TCRdelta': 1, 'chlorhexidine': 4, 'octenidine': 1, 'February': 2, 'Kyoto': 1, 'SSI': 2, 'dexamethasone': 8, 'antiemetic': 3, 'analgesic': 3, 'conservationists': 1, 'letermovir': 4, 'iron': 5, 'cagE': 2, 'Anaerobes': 1, 'calcineurin inhibitor': 1, 'calcineurin inhibitors': 1, 'tacrolimus': 1, 'mycophenolate mofetil (MMF)': 1, 'MMF': 1, 'steroid': 1, 'EMBASE': 1, 'CINAHL': 1, 'September': 1}, 'bleeding': {'heparin': 3, 'vitamin K antagonists)': 1, 'rivaroxaban': 2, 'antibiotics': 1, 'anticoagulation': 18, 'anticoagulants': 4, 'chemoprotective': 1, 'aspirin': 35, 'Cochrane': 1, 'ticagrelor': 3, 'clopidogrel': 10, 'January': 4, 'hemopericardium': 1, 'thromboprophylaxis': 2, 'anesthesia': 3, 'September': 2, 'methotrexate': 2, 'October': 2, 'paracetamol': 1, 'carboxypeptidase inhibitor': 1, 'fibrinolysis inhibitor (TAFIa)': 1, 'PTCI': 2, 'thrombolytic': 1, 'chemotherapy': 2, 'bevacizumab': 1, 'Scopus': 2, 'PMCT': 2, 'PMMRI': 2, 'tranexamic acid (TXA)': 1, 'August': 1, '10,381': 1, 'mono antiplatelet therapy': 1, 'fulguration': 1, 'antiplatelet': 1, 'anticoagulant': 1, 'Paracetamol': 1, 'Ketorolac': 1, 'Reepithelisation': 1, 'nonselective beta-blockers (OR = 0.294': 1, 'tranexamic acid': 1, 'reoperate': 1, 'AnTicoagulation': 1, 'vitamin K antagonist': 1, 'antiarrhythmic': 1, 'Digoxin': 1, 'warfarin': 13, 'venoocclusion': 1, 'Reintervention': 1, 'Hemostatic': 1, 'steroid': 3, 'steroids': 2, 'Aspirin': 4, 'Unfractionated': 1, 'fondaparinux': 1, 'ADP receptor inhibitor': 1, 'thrombin inhibitor': 1, 'p<0.001': 1, 'chemoprophylactic': 1, 'antitoxin': 1, 'nonhypertensive': 1, 'albumin': 1, 'hepatectomy': 1, 'LR': 1, 'glutaraldehyde': 1, 'Embase': 1, 'MEDLINE': 1, 'Warfarin': 1, 'apixaban': 1, 'DOACs': 1, 'alphaIIbbeta3 antagonist, but does not compromise primary hemostasis. Specific targets are revealed for a preferential inhibition of thrombosis that may lead to new classes of potent antithrombotics without hemorrhagic side effects.BACKGROUND: Thromboembolism-associated stroke is the most feared complication of Atrial fibrillation (AF)': 1, 'analgesics': 1, 'PIMs': 1, 'sedative medications': 1, 'IRPE': 1, 'Intecc': 1, 'prednisolone': 2, 'immunoglobulin': 3, 'IVIG': 1, 'dexamethasone': 1, 'Haemtrack': 2, 'megakaryopoiesis': 1, 'megakaryocyte': 1, 'VWF': 1, 'megakaryocytes': 1}, 'death': {'PPI': 1, 'sulfamethoxazole': 1, 'LYC': 1, 'Claudins': 1, 'Occludin': 1, 'malondialdehyde': 2, 'Heme oxygenase 1)': 1, 'interleukin (IL)-1beta, IL-6': 1, 'IL-8': 1, 'interferon regulatory factor': 1, 'doxorubicin': 2, 'bortezomib': 1, 'proteasome inhibitors': 1, 'chlorhexidine gluconate (CHG) bathing to decrease healthcare associated infections (HAI)': 1, 'anticoagulation': 4, 'anticoagulants': 1, 'Killip': 1, 'chemotherapy': 23, 'Japan': 1, 'Formalin': 1, 'ferroptosis': 1, 'ticagrelor': 3, 'clopidogrel': 6, 'interactions': 1, 'PFS': 1, 'platinum': 1, 'etoposide': 1, 'nanocarrier': 1, 'paclitaxel': 1, 'Glutathione peroxidase': 1, 'IL-6': 1, 'hepatic insulin': 1, 'Adipocyte': 1, 'mTNBC': 1, 'ECMO': 1, 'Kyoto': 1, 'chemoimmunotherapy': 1, 'TNBC': 2, 'cannabidiol': 1, 'Quercetin': 1, 'scopolamine': 1, 'October': 3, 'infused': 1, 'phosphate-buffered saline': 1, 'tisagenlecleucel': 2, 'chemo': 5, 'methylene blue': 1, 'PD-1 checkpoint blockade further evokes a series of systemic immunity responses that suppress distant tumor growth and the pulmonary metastasis of breast cancer, as well as offer': 1, 'oxaliplatin': 5, 'nivolumab': 8, 'capecitabine': 1, 'Nivolumab': 1, 'antiarrhythmic': 2, 'amiodarone': 3, 'albendazole': 1, 'CHOP': 2, 'GRP78': 1, 'porcine Kobuvirus (PKoV)': 1, 'mRNAs': 2, 'trametinib': 3, 'spartalizumab': 1, 'statin': 1, 'vitamin K': 1, 'vitamin K supplementation': 1, 'Vitamin K supplementation is required': 1, 'Amantadine': 1, 'modafinil': 7, 'amantadine': 7, 'sedative medications': 1, 'SOC therapies': 1}, 'cancer': {'January': 4, 'chemotherapy': 22, 'cisplatin': 1, 'gemcitabine': 1, 'oxaliplatin': 1, 'kinase inhibitor': 1, 'TLR agonists': 1, 'Telratolimod': 1, 'photothermal': 4, 'PGP': 6, 'CaCO3@IR820': 7, 'docetaxel': 1, 'hyaluronic acid': 1, 'Hyaluronic acid (HA)': 1, 'LipoBOD': 3, 'tumourigenesis': 1, 'interleukin (IL)-1beta, IL-6': 1, 'IL-8': 1, 'interferon regulatory factor': 1, 'sulfhydryl-polyethylene glycol-folate (SH-PEG-FA)': 1, "Peyer's patches (PPs)": 1, 'transmembrane protease serine': 1, 'antibiotic': 3, 'clarithromycin': 1, 'metronidazole': 1, 'levofloxacin': 1, 'amoxicillin': 1, 'September': 3, 'intratumoral': 1, 'TLR6': 1, 'doxorubicin': 1, 'bortezomib': 1, 'proteasome inhibitors': 1, 'nivolumab': 2, 'cabozantinib': 6, 'CRS': 1, 'EMBASE': 1, 'PsycINFO': 1, 'August': 2, 'radiolabeled': 1, 'Chemo': 2, 'Magnetite nanoparticles coated with L-ascorbic acid (size ~ 25.0 nm)': 1, 'MNPs': 1, 'intraperitoneally': 1, 'glucose analogs': 1, 'GnRH analogs': 1, 'NHSII': 1, 'phenylacetylglutamine': 1, 'Izmir': 1, 'Ataturk': 1, 'SUVpeak': 2, 'SUVapex': 1, 'OSEM': 1, 'estrogens': 3, 'estradiol': 1, 'resectable': 1, 'Ovid Embase': 1, 'CINAHL': 1, 'Japan': 1, 'Formalin': 1, 'IYIY': 1, 'lipidomic': 1, 'ketal': 1, 'polyethylene glycol (PEG)': 1, 'dimethylarsonic acid (DMA(III)Gl)': 1, 'dimethylarsic acid (DMA((III)))': 1, 'methylarsonic acid (MMA(V)': 1, 'dimethylarsonic acid (': 1, 'tetramethylarsonium chloride (TETPA)': 1, 'trimethylarsine oxide (TMAO)': 1, 'ferric ion': 1, 'dopamine': 1, 'metabolite citrate': 1, 'citrate': 3, 'hydrogen sulfide (H2 S)': 1, 'GSMs': 1, 'PFS': 1, 'platinum': 1, 'etoposide': 1, 'Plxns': 1, 'synthesize analogs': 1, 'pharmacokinetics': 1, 'dLNM': 1, 'hsa': 1, '+0.12': 1, 'statin': 1}, 'SARS-CoV-2 infection': {'MetaDisc': 1, 'fibrinolysis': 2, 'procoagulant': 1, 'antifibrinolytic': 1, 'tPA': 2, 'thromboprophylaxis': 2, 'clonazepam': 1, 'methylprednisolone': 1, '12/08/2021': 1, 'dimethyl fumarate (DMF)': 1, 'Chan Zuckerberg Biohub (JLD)': 1, 'casirivimab': 2, 'imdevimab': 3, 'Casirivimab': 1, 'imdevimab antibody combination vs': 1, 'hydroxychloroquine': 1, 'azithromycin': 1, 'Corticosteroids': 1, 'cyclophosphamide': 1, 'Bryopsidophyceae': 1, 'Chlorophyta': 1, 'sulfate substitution': 1, 'February': 3, 'KFD': 1, 'continve': 1, 'amino acid substitution': 1, 'January': 1, 'corticosteroids': 3, 'inositol phosphate metabolism': 2, 'myofibroblast': 1, 'fibrogenesis': 1, 'STING': 1, 'Diasorin': 2, 'Saluggia': 1, 'Roche': 1, 'Human recombinant monoclonal antibodies (mAbs)': 1, 'heparan sulfate': 1, 'Coronavirinae': 1, 'Betacoronavirus': 1, 'BioNTech': 1, 'September': 3, 'bamlanivimab': 1, 'mRNA': 1, 'PRNT': 1, 'Amparo': 1, 'Pesquisa': 1, 'Bali': 1, 'Indonesia': 1, 'linagliptin': 2, 'insulin': 3, 'opioids': 1, 'Taipei': 2, 'August': 2, 'enoxaparin': 1, 'prednisone': 1, 'methotrexate': 1, 'October': 1}, 'coronavirus infectious disease': {'October': 1, 'Pfizer': 1, 'antimicrobials': 1, 'corticosteroids': 3, 'remdesiver': 1, 'oseltamivir': 1, 'ritonavir': 1, 'ribavirin': 1, 'anticoagulant': 1, 'vitamin C': 3, 'February': 4, 'chloroquine': 1, 'lopinavir': 2, 'CIDO': 3, 'CRISPR': 3, 'epi': 2, 'January': 2, 'Scopus': 2, 'immunoglobulin': 1, 'steroids': 4, 'dopamine': 1, 'norepinephrine': 1, 'Micrococcaceae': 1, 'essential mineral immunomodulator': 1, 'Embase': 1, 'corticosteroid': 1, 'Vaping': 1, 'heparin': 3, 'anticoagulants': 1, 'receptor antagonist': 1, 'methylprednisolone': 1, 'ruxolitinib': 1, 'dexamethasone': 5, 'vancomycin': 1, 'metronidazole': 1, 'methylene blue dye': 1, 'PPIs': 2, 'ketotifen': 4, 'naproxen': 5, 'indomethacin': 5, 'metformin': 9, 'insulin': 1, 'Metformin': 3, 'AMPK': 1, 'glucagon': 1, 'rapamycin': 1, 'propofol': 1, 'midazolam': 1, '57,641 compounds': 1, 'antivirals': 1, 'AT1R': 1, 'thiopurines': 1, 'IL-8': 1, 'RDV': 1, 'tocilizumab': 1}, 'venous thrombosis': {'heparin': 17, 'vitamin K antagonists)': 1, 'rivaroxaban': 3, 'antibiotics': 2, 'anticoagulation': 17, 'rituximab': 3, 'anticoagulants': 4, 'interactions': 1, 'Plinear': 2, 'Osteoprotegerin': 1, 'atorvastatin': 2, 'plasma': 1, 'Dhahran': 1, 'Saudi': 1, 'Arabia': 1, 'CBIs': 1, 'PoCUS': 2, 'acyclovir': 1, 'Warfarin': 2, 'apixaban': 3, 'posttreatment': 3, 'Apixaban': 1, 'AstraZeneca': 5, 'steroids': 2, 'immunoglobulin': 1, 'fondaparinux': 1, 'anesthesia': 1, 'January': 6, 'testosterone': 3, 'statins': 1, 'nitric oxide donors': 1, 'DOACs': 1, 'chemoprophylaxis': 2, 'enoxaparin': 1, 'Fondaparinux': 1, 'Enoxaparin': 1, 'antiplatelets': 1, 'thrombolytic': 2, 'Histotripsy': 1, 'PMR': 1, 'September': 1, 'hypofibrinogenemia': 1, 'Japan': 1, 'vasopressor': 2, 'contrast': 1, 'anticoagulant therapies, most of the patients improved or discharged. Conclusion: As long as the laboratory findings are not appropriate enough to predict PVT': 1, 'Hinari': 1, 'Embase': 1, 'Anticoagulants': 2, 'Anticoagulant': 1, 'CRVT': 1, 'steroid': 1, 'thrombolytics': 1, 'phlebectomy': 1, 'October': 2, 'Univariate': 1, 'anticoagulant': 3, 'vitamin K antagonists (VKAs)': 1, 'contraceptives': 1, 'progestin': 2, 'EVLA': 4, 'Polidocanol': 1, 'FPHL': 1, 'CNKI': 1, 'Wanfang': 1, 'Cochrane databases': 1, 'LMWH': 1, 'dextran': 2, 'unfractionated': 4, 'concomitantly': 2, 'Heparin': 1, 'warfarin': 1, 'Unfractionated': 1, 'Dextran': 1, 'chemotherapy': 1, 'retromolar': 1, 'hyperimmune plasma': 1, 'VTE': 1, 'antifibrinolytic': 1, 'EPCs': 2, 'Ang1': 1, 'cyclophosphamide': 1, 'portoesplenomesenteric': 1, 'Pfizer': 1, 'chronic lithium': 1, 'lithium': 2, 'anticoagulant (DOAC)': 1, 'November': 1, 'red blood cells': 1, 'procoagulant': 1}, 'pandemic': {'GIIs': 1, 'opioid': 5, 'opioid agonist therapy (OAT)': 1, 'September': 2, 'transmembrane protease serine': 1, 'antibiotics': 7, 'tetracycline': 1, 'ciprofloxacin': 1, 'sulfamethoxazole': 1, 'triclosan': 1, 'DFMs': 6, 'antibiotic': 2, 'antiperistaltic': 1, 'probiotics': 1, 'antibacterials': 1, 'biosensing': 1, 'autoepitopes': 1, 'Netherlands': 2, 'Germany': 1, 'Belgium': 1, 'Greece': 1, 'Poland': 1, 'Sweden': 1, 'albumin': 1, 'steroids': 1, 'anesthesia': 1, 'January': 2, 'buprenorphine': 8, 'mu opioid agonist': 1, 'opioids': 1, 'full agonist opioids': 1, 'chronic buprenorphine': 1, 'October': 2, 'GARCH': 1, 'Diebold': 1, 'November': 1, 'overdoses': 1, 'naloxone': 8, 'Naloxone': 1, 'narcotic': 1, 'February': 1}, 'infections': {'PsychInfo': 1, 'GIIs': 1, 'January': 5, 'corticosteroids': 1, 'antibiotic': 13, 'chloramphenicol': 2, 'Rdn': 1, 'Chpl': 1, 'vancomycin': 11, 'antivirulence': 1, 'chlorhexidine gluconate (CHG) bathing to decrease healthcare associated infections (HAI)': 1, 'probiotics': 2, 'antifungals': 1, 'antifungal': 2, 'Pseudocitrobacter': 1, 'cephalosporins': 1, 'carbapenems': 1, 'trimethoprim-sulfamethoxazole': 1, 'amikacin': 1, 'rituximab': 3, 'anticoagulation': 2, 'Theileriosis': 1, 'Opisthorchiidae': 1, 'Heterophyidae': 1, 'Schistosomatidae': 1, 'Wnt ligands': 1, 'antibiotics': 7, 'sacubitril': 1, 'valsartan': 1, 'lactic acid bacteria (LAB)': 1, 'biosensing': 1, 'autoepitopes': 1, 'dextran sulfate sodium': 1, 'UTIcalc': 2, 'Gorelick': 2, 'Belgium': 1, 'Netherlands': 1, 'Greece': 1, 'Poland': 1, 'Sweden': 1, 'TCRdelta': 1, 'chlorhexidine': 4, 'octenidine': 1, 'February': 2, 'Embase': 1, 'spPCR': 1, 'upsA': 1, 'upsB': 1, 'meropenem': 1, 'Anaerobes': 1, 'diuretic': 2, 'nalidixic acid': 1, 'nalidixic acid and divalent magnesium': 1, 'gentamicin': 3, 'silica nanocarriers': 1, 'Antibiotic': 3, 'rifampicin': 9, 'immunomodulation': 1, 'tetracycline': 3, 'doxycycline': 1, 'gemifloxacin': 1, 'beta-lactam resistance. Nevertheless, the': 1, 'Iran': 1, 'normal saline': 2, 'injectables': 2, '12/08/2021': 1, 'chloroquine': 1, 'eligilibity': 1, 'albendazole': 1, 'CHOP': 2, 'GRP78': 1, 'AE.BACKGROUND': 1, 'October': 1, 'November': 1, 'ciprofloxacin': 1, 'hyaluronic acid (HA)': 1, 'thyrotoxic': 1, 'aminoglycosides': 1, 'tobramycin': 6, 'September': 1, 'vasopressor': 1, 'spondylarthritis': 1, 'nonsteroidal': 1, 'Rubisco': 1, 'amino acids': 1, 'melatonin': 1, 'chemotherapy': 1, 'levofloxacin': 4, 'ceftazidime': 2, 'cefepime': 1, 'interactions': 1, 'Swedish': 1, 'dimethyl fumarate (DMF)': 1, 'DMT': 1, 'phages': 1, 'amino acid transport': 1, 'Immunoblotting': 1, 'betadine': 5, 'SSI': 3, '30-': 1, 'bevacizumab': 1, 'Vancomycin': 1, 'interferon alpha/peginterferon alpha (IFNalpha/Peg-IFNalpha)': 1, 'Rifabutin': 2, 'rifabutin': 2, 'Baculoviruses Autographa californica multicapsid': 1, 'metagenomic': 1, 'voriconazole': 1}, 'coronavirus infectious disease 2019': {'October': 1, 'Pfizer': 1, 'antimicrobials': 1, 'remdesiver': 1, 'oseltamivir': 1, 'ritonavir': 3, 'ribavirin': 1, 'anticoagulant': 1, 'vitamin C': 3, 'February': 3, 'CRISPR': 3, 'Micrococcaceae': 1, 'Scopus': 1, 'Embase': 1, 'Vaping': 1, 'January': 2, 'ruxolitinib': 1, 'dexamethasone': 7, 'vancomycin': 1, 'metronidazole': 1, 'methylene blue dye': 1, 'PPIs': 2, 'propofol': 1, 'midazolam': 1, '57,641 compounds': 1, 'antivirals': 1, 'heparin': 2, 'steroids': 4, 'RDV': 1, 'corticosteroids': 2, 'lopinavir': 3, 'tocilizumab': 2, 'beclin': 1, 'ACE2': 1, 'ACE inhibitors': 1, 'ACE homologues': 1, 'hydroxychloroquine': 2, 'Bruneian': 1, 'Allplex': 5, 'PowerChek': 4, 'corticosteroid': 1, 'Paris': 1, 'Agence': 1, 'azithromycin': 1, 'calcineurin inhibitor (71.4': 1, 'mycophenolate mofetil': 1, 'amino acid ergothioneine': 1, 'sodium hypochlorite': 2}, 'thrombosis': {'heparin': 4, 'vitamin K antagonists)': 1, 'rivaroxaban': 1, 'antibiotics': 1, 'anticoagulation': 8, 'platelets': 2, 'intragastric': 1, 'APTT': 1, 'TT': 1, 'rituximab': 2, 'October': 1, 'TPN': 1, 'thromboprophylaxis': 2, 'FVIIa': 1, 'aspirin': 8, 'Aspirin': 1, 'AstraZeneca': 3, 'Cyanocobalamin': 1, 'IQR': 1, 'cyanocobalamin': 1, 'anticoagulants': 1, 'anticoagulant': 1, 'chemotherapy': 7, 'Streptokinase': 1, 'urokinase': 1, 'venoocclusion': 1, 'Reintervention': 1, 'fresh frozen plasma': 1, 'SCT': 1, 'January': 3, 'nitric oxide': 2, 'albumin': 1, 'antiplatelet': 2, 'LR': 1, 'interactions': 2, 'Plinear': 2, 'Osteoprotegerin': 1, 'atorvastatin': 2, 'September': 3, 'plasma': 1, 'alphaIIbbeta3 antagonist, but does not compromise primary hemostasis. Specific targets are revealed for a preferential inhibition of thrombosis that may lead to new classes of potent antithrombotics without hemorrhagic side effects.MicroRNAs (miRNAs) are small noncoding regulatory RNA molecules that play a significant role in targeted downregulation of gene expression by RNA silencing and posttranscriptional regulation': 1, 'August': 1, 'warfarin': 1, 'steroids': 2, 'immunoglobulin': 2, 'fondaparinux': 1, 'prednisolone': 1, 'IVIG': 1, 'Dhahran': 1, 'Saudi': 1, 'Arabia': 1, 'GPVI': 1, 'polyvinyl chloride (PVC)': 1, 'ethylene oxide': 1, 'antiphosphatidylserine': 1, 'ECMO': 3, '29,256': 1, 'Thrombin Receptor Activator Peptide': 1, 'vasopressors': 1, 'thrombolysis': 1, 'ubiquitous oxygen': 1, 'Hydrofluoric acid (HF)': 1, 'sirolimus': 1, 'bioresorbable': 1, 'chondroitin sulfate (CS)': 1, 'thrombolytic': 1, 'February': 1, 'nonselective beta blockers': 1, 'CPVET': 1, 'MACHS': 1, 'cefazolin': 4, 'sodium citrate': 2, 'gentamicin': 2, 'sodium citrate stored': 1, 'Gentamicin': 1, 'Cardioembolism': 1, 'graft chondroitin sulfate (CS)': 1, 'VWD': 3, 'desmopressin': 1, 'emicizumab': 2, 'Humate': 1, 'DPHL': 1}}